Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
C-Rad AB Class B ( ($SE:CRAD.B) ) has provided an announcement.
C-RAD AB, a global leader in Surface Guided Radiation Therapy, is using the ESTRO 2026 conference in Stockholm to showcase enhancements to its flagship Catalyst HD system and introduce Catalyst LITE, underscoring a strategy centered on customer-led, clinician-informed innovation. The company is highlighting workflow and interface improvements designed with clinical partners, a modular upgrade path for clinics adopting SGRT, and tailored Meet the Expert sessions, positioning C-RAD to deepen its role in oncology workflows and support wider, more efficient adoption of tattoo-free, motion-managed radiotherapy worldwide.
More about C-Rad AB Class B
C-RAD AB is a Sweden-based medical technology company specializing in surface-guided imaging solutions for radiation therapy. Its systems use high-speed 3D cameras and augmented reality to support precise patient setup and real-time motion monitoring, with the goal of delivering accurate tumor dose while protecting healthy tissue and improving patient comfort, without tattoos or additional imaging dose.
Average Trading Volume: 23,856
Technical Sentiment Signal: Buy
Current Market Cap: SEK1.16B
For detailed information about CRAD.B stock, go to TipRanks’ Stock Analysis page.